ClinConnect ClinConnect Logo
Search / Trial NCT01144091

Renal Effect of Pentoxyphylline in High Risk Patients Undergoing Angiography

Launched by MEIR MEDICAL CENTER · Jun 14, 2010

Trial Information

Current as of July 21, 2025

Withdrawn

Keywords

Diabetes Mellitus Creatinin Level Contrast Induced Nephropathy Prevention Contrast Induced Nephropathy In High Risk Patients

ClinConnect Summary

Impairment of renal function following exposure to intravenous radio-graphic contrast materials is the third major cause of renal hospital acquired renal dysfunction. Renal dysfunction occurs most often in patients with chronic renal failure and or patients with diabetes mellitus and contributes to the morbidity and mortality. Previous research work proved that the use volume expansion with N-acetyl cysteine (NAC) is superior to volume expiation alone to prevent renal impairment due to radio-contrast5. NAC a potent anti oxidant may prevent CIN by stopping direct oxidative tissue damage and ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Cardiology patients:
  • 1. Hospitalization for ACS (acute coronary syndrome) with NSTEMI or Unstable Angina
  • 2. Diabetic patients (treated with insulin or oral hypoglycemic drugs) or patients with basal serum creatinine greater than 1.3mg/dl in females and 1.5 mg/dl in male patients.
  • 3. Informed consent
  • 4. Age between 18-75
  • Radiology patients:
  • 1. Radiology patients should be diabetic patients (treated with insulin or oral hypoglycemic drugs) or patients with basal serum creatinine of 1.3mg/dl in females and 1.5 mg/dl in male patients.
  • 2. Informed consent
  • 3. Age between 18-75

About Meir Medical Center

Meir Medical Center is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. As a prominent sponsor of clinical studies, Meir Medical Center is committed to fostering collaboration among healthcare professionals, researchers, and patients to explore new therapies and treatment modalities. With a focus on ethical practices and patient safety, the center aims to contribute significantly to the scientific community while enhancing the quality of care provided to its diverse patient population. Through its robust infrastructure and multidisciplinary approach, Meir Medical Center stands at the forefront of medical innovation, driving progress in various therapeutic areas.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials